-
Reframing HIV Prevention Through Community, Trust, and Equity
Every December, HIV Awareness Month urges us not only to reflect on medical breakthroughs, but also to confront the inequities that endure despite them. Modern antiretroviral…
Community, Research -
The Lundquist Institute and Its Start-Up Company Vitalex Biosciences Announce Strategic Advancement of Second-Generation Fungal Vaccine VXV-01 Through Phase 1 Trials Under $40 Million Competitive Contract From NIH/NIAID
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal vaccine candidate known as VXV01, which was…
Innovation, Research -
-
Bridging Research and Care: Dr. Christine Dauphine on Breast Cancer Risk and Prevention
October marks Breast Cancer Awareness Month — a time to educate, empower, and encourage proactive screening. To help shed light on prevention, early detection, and ongoing…
Research -
Bacteria inside melanoma tumors may offer clues about cancer outcomes
A new study in the Journal of Investigative Dermatology led by Dr. Delphine J. Lee suggests that the bacterial community inside melanoma tumors, also known as…
Research -
The Swidergall Lab receives NIH/NIAID funding to advance neonatal immunity research
Candida albicans, a common fungus found in and on the body, is typically harmless but can cause disease in immunocompromised individuals. In humans, colonization of the…
Research -
The Lundquist Institute Scientist Nicholas Jendzjowsky, PhD Receives Prestigious NIH Grant to Advance Pneumonia Research
The Lundquist Institute is proud to announce that Nicholas Jendzjowsky, PhD and his research team have been awarded a highly competitive $3.3 million, five-year R01 grant…
Research -
-
-
